, Volume 37, Issue 6, pp 755–760 | Cite as

Do Non-Steroidal Anti-Inflammatory Agents Have a Role in the Treatment of Migraine Headaches?

  • Seymour Diamond
  • Frederick G. Freitag
Leading Article


Migraine Naproxen Cluster Headache Naproxen Sodium Ergotamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ala-Hurula V, Myllyla VV, Hokkanen E, Tokola O. Tolfenamic acid and ergotamine abuse. Headache 21: 240–242, 1981PubMedCrossRefGoogle Scholar
  2. Amano T, Meyer JS. Prostaglandin inhibition and cardiovacular control in patients with headache. Headache 22: 52–59, 1982PubMedCrossRefGoogle Scholar
  3. Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Archives of Neurology 16: 544, 1967PubMedCrossRefGoogle Scholar
  4. Anthony M, Hinterberger H, Lance JW. The possible relationship of serotonin to the migraine syndrome. Research and Clinical Studies in Headache 2: 29, 1968Google Scholar
  5. Apter JT, Apter AS, Tyano S. Side effects and toxicity of lithium. Journal of Family Practice 15(6): 1101–1106, 1982PubMedGoogle Scholar
  6. Boghen D, Desaulniers N. Background vascular headache: relief with indomethacin. Canadian Journal of Neurological Sciences 10: 270–271, 1983PubMedGoogle Scholar
  7. Carasso RL, Peled O, Yehuda S. Flufenamic acid in prostaglandin migraine. International Journal of Neuroscience 27: 67–71, 1985PubMedCrossRefGoogle Scholar
  8. Curran DA, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 88: 997, 1965PubMedCrossRefGoogle Scholar
  9. Deshmukh SV, Meyer JS. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache 17: 101–108, 1977PubMedCrossRefGoogle Scholar
  10. Diamond S. Prolonged benign exertional headache: its clinical characteristics and response to indomethacin. Headache 22: 96–98, 1982PubMedCrossRefGoogle Scholar
  11. Diamond S, Dalessio DJ. The practicing physician’s approach to headache, 4th ed., pp. 61–63, Williams & Wilkins, Baltimore, 1986Google Scholar
  12. Diamond S, Medina JL. Cluster headache variant. Archives of Neurology 38: 705–709, 1981PubMedCrossRefGoogle Scholar
  13. Diamond S, Medina JL. Prolonged benign exertional headache: clinical characteristics and response to indomethacin. In Critchley M, et al. (Eds) Advances in Neurology, Vol. 33, pp. 145–149, Raven Press, New York, 1982Google Scholar
  14. Diamond S, Solomon GD, Freitag FG, Mehta ND. Fenoprofen in the prophylaxis of migraine: a double-blind, placebo controlled study. Headache 27: 246–249, 1987PubMedCrossRefGoogle Scholar
  15. Hakkarainen H, Parantainen J, Gothoni G, Vapaatalo H. Tolfenamic acid and caffeine: a useful combination in migraine. Cephalalgia 2: 173–177, 1982PubMedCrossRefGoogle Scholar
  16. Hakkarainen H, Vapaatalo H, Gothoni G, Parantainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 2: 326–327, 1979PubMedCrossRefGoogle Scholar
  17. Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia 5: 5–10, 1985PubMedCrossRefGoogle Scholar
  18. Lindegaard KF, Ovrelid L, Sjaastad O. Naproxen in the prevention of migraine attacks: a double-blind placebo-controlled crossover study. Headache 20: 96–98, 1980PubMedCrossRefGoogle Scholar
  19. Masel BE, Chesson AL, Peters BH, Levin HS, Alperin JB. Platelet antagonists in migraine prophylaxis. Headache 20: 13–18, 1980PubMedCrossRefGoogle Scholar
  20. Mathew NT. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 27: 130–133, 1987PubMedCrossRefGoogle Scholar
  21. Medina JL, Diamond S. Cluster headache variant. Archives of Neurology 38: 705–709, 1981PubMedCrossRefGoogle Scholar
  22. Mikkelsen BM, Falk JV. Prophylactic treatment of migraine with tolfenamic acid. Acta Neurologica Scandinavica 66: 105–111, 1982PubMedCrossRefGoogle Scholar
  23. Nestvold K. Naproxen and naproxen sodium in acute migraine attacks. Cephalalgia 6 (Suppl. 4): 81–84, 1986PubMedGoogle Scholar
  24. Nestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 5: 115–119, 1985PubMedCrossRefGoogle Scholar
  25. O’Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet 2: 1179–1181, 1978PubMedCrossRefGoogle Scholar
  26. Paulson GW, Klawans HL. Benign orgasmic cephalalgia. Headache 13: 181–187, 1974PubMedCrossRefGoogle Scholar
  27. Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 3: 129–134, 1983PubMedCrossRefGoogle Scholar
  28. Pendergrass PB, Scott JN, Ream LJ, Agna MA. Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache. Gynecologic and Obstetric Investigation 19: 32–37, 1985PubMedCrossRefGoogle Scholar
  29. Peterson DI. Headache. Part IX: nonsteroidal antiinflammatory drugs for the treatment of headache. Internal Medicine for the Specialist 7(11): 69–77, 1986Google Scholar
  30. Pradalier A, Rancurel G, Dordain G, Verdure L, Rascol A. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia 5: 107–113, 1985PubMedCrossRefGoogle Scholar
  31. Rabey JM, Vardi J, Zor Val Schwartz A. Treatment of migraine by antiprostaglandin. Harefuah 91: 387–388, 1976PubMedGoogle Scholar
  32. Ross-Lee L, Heazlewood V, Tyrer JH, Eadie MJ. Aspirin treatment of migraine attacks: plasma drug level data. Cephalalgia 2: 9–14, 1982PubMedCrossRefGoogle Scholar
  33. Sargent J, Solbach P, Damasio H, Baumel B, Corbett J. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 25: 320–324, 1985PubMedCrossRefGoogle Scholar
  34. Sargent JD, Baumel B, Peters K, Diamond S, Saper JR. Aborting a migraine attack: naproxen sodium v. ergotamine plus caffeine. Headache 28: 263–266, 1988PubMedCrossRefGoogle Scholar
  35. Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in hydroxyindoleacetic acid excretion during migraine attacks. International Archives of Allergy and Applied Immunology 19: 55, 1961CrossRefGoogle Scholar
  36. Simon LD, Mills JA. Nonsteroidal antiinflammatory drugs. New England Journal of Medicine 302(21): 1179–1185, 1980PubMedCrossRefGoogle Scholar
  37. Sjaastad O, Apfelbaum R, Caskey W, Christoffersen B, Diamond S, et al. Chronic paroxysmal hemicrania (CPH); the clinical manifestations: a review. Upsala Journal of Medical Sciences (Suppl. 31): 27–33, 1980Google Scholar
  38. Sjaastad P, Egge K, Horven I, Kayed K, Lund-Roland L, et al. Chronic paroxysmal hemicrania: mechanical precipitation of attacks. Headache 19: 31–36, 1979PubMedCrossRefGoogle Scholar
  39. Steardo L, Sorge F, Florio C. Efficacy of flufenamic acid in migraine attacks. Acta Neurologica (Napoli) 34(4): 271–277, 1979Google Scholar
  40. Stensrud P, Sjaastad O. Clinical trial of a new anti-bradykinin, anti-inflammatory drug, ketoprofen (19,583 R.P.) in migraine prophylaxis. Headache 14: 96–100, 1974PubMedCrossRefGoogle Scholar
  41. Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 4: 107–111, 1984PubMedCrossRefGoogle Scholar
  42. Vardi J, Rabey JM, Streifler M. Prostaglandins and their synthesis inhibitors in migraine. In Karim SS (Ed.) Prostaglandins, pp. 139–148, MTP Press, Lancaster, 1979Google Scholar
  43. Walshe JJ, Venuto RC. Acute oliguric renal failure induced by indomethacin: possible mechanism. Annals of Internal Medicine 91: 41–49, 1979Google Scholar
  44. Welch KMA. Naproxen sodium in the treatment of migraine. Cephalalgia 6 (Suppl. 4): 85–92, 1986PubMedGoogle Scholar
  45. Welch KMA, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology 35: 1304–1310, 1985PubMedCrossRefGoogle Scholar
  46. Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Archives of Neurology 42: 582–584, 1985PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1989

Authors and Affiliations

  • Seymour Diamond
    • 1
    • 2
    • 3
    • 4
  • Frederick G. Freitag
    • 1
    • 2
    • 3
    • 4
  1. 1.Diamond Headache Clinic Ltd and Inpatient Headache UnitLouis A. Weiss Memorial HospitalChicagoUSA
  2. 2.Department of PharmacologyChicago Medical SchoolChicagoUSA
  3. 3.Department of Family MedicineChicago College of Osteopathic MedicineChicagoUSA
  4. 4.Department of MedicineUniversity of ChicagoChicagoUSA

Personalised recommendations